Related Experiment Videos
Growth factors in bladder cancer
1Department of Urology and Cell Biology, The University of Texas, Houston 77030, USA.
Abstract:
This article is an overview of peptide growth factors, their receptors, and signal-transduction pathways that play a role in bladder cancer. Included in this overview are epidermal growth factor receptor and its ligands, erbB2, fibroblast growth factors, insulin-like growth factor, the transferrin receptor, and transforming growth factor-beta. The use of growth factors or growth factor receptors for diagnostic and therapeutic interventions is also discussed.
Insights
This review covers peptide growth factors and their receptors involved in bladder cancer. It explores their role in signal-transduction pathways and potential diagnostic and therapeutic applications.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Peptide growth factors and their receptors are crucial in cellular processes.
- Aberrant signaling pathways involving growth factors are implicated in various cancers, including bladder cancer.
Purpose of the Study:
- To provide a comprehensive overview of peptide growth factors, their receptors, and associated signal-transduction pathways in bladder cancer.
- To discuss the potential of these molecules for diagnostic and therapeutic strategies in bladder cancer.
Main Methods:
- Literature review and synthesis of existing research on growth factors and bladder cancer.
- Detailed examination of specific growth factors: epidermal growth factor receptor (EGFR) and its ligands, erbB2, fibroblast growth factors (FGFs), insulin-like growth factor (IGF), transferrin receptor (TfR), and transforming growth factor-beta (TGF-β).
Main Results:
- Several growth factors and receptors, including EGFR, erbB2, FGFs, IGF, TfR, and TGF-β, are dysregulated in bladder cancer.
- These molecules activate specific signal-transduction pathways that promote tumor growth, proliferation, and metastasis.
- The identified pathways represent potential targets for novel therapeutic interventions.
Conclusions:
- Growth factors and their receptors are key players in bladder cancer pathogenesis.
- Targeting these pathways holds promise for developing innovative diagnostic tools and effective treatments for bladder cancer.